rs201120508
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_012144.4(DNAI1):c.180G>A(p.Ala60=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000867 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_012144.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.180G>A | p.Ala60= | splice_region_variant, synonymous_variant | 3/20 | ENST00000242317.9 | NP_036276.1 | |
DNAI1 | NM_001281428.2 | c.180G>A | p.Ala60= | splice_region_variant, synonymous_variant | 3/20 | NP_001268357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.180G>A | p.Ala60= | splice_region_variant, synonymous_variant | 3/20 | 1 | NM_012144.4 | ENSP00000242317 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251464Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135914
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000756 AC XY: 55AN XY: 727248
GnomAD4 genome AF: 0.000171 AC: 26AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74334
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2023 | The c.180G>A variant (also known as p.A60A), located in coding exon 3 of the DNAI1 gene. This variant results from a G to A substitution at nucleotide position 180. This nucleotide substitution does not change the alanine at codon 60. However, this change occurs in the last base pair of coding exon 3, which makes it likely to have some effect on normal mRNA splicing. This variant was identified in an individual with primary ciliary dyskinesia with outer dynein arm defects in conjunction with a DNAI1 frameshift variant; however, phase information was not provided (Blanchon S et al. J Med Genet, 2020 Apr;57:237-244). This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site and will result in the creation or strengthening of a novel splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change affects codon 60 of the DNAI1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the DNAI1 protein. This variant also falls at the last nucleotide of exon 3, which is part of the consensus splice site for this exon. This variant is present in population databases (rs201120508, gnomAD 0.02%). This variant has been observed in individual(s) with clinical features of primary ciliary dyskinesia (PMID: 31772028; Invitae). ClinVar contains an entry for this variant (Variation ID: 260201). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 13, 2020 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 19, 2023 | Reported with a second DNAI1 variant, phase unknown, in a patient with an outer dynein arm defect (Blanchon et al., 2020); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: Catana_2022_CaseReport, 31772028) - |
DNAI1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The DNAI1 c.180G>A variant occurs at the final base of exon 3 and is predicted to interfere with normal splicing (Splice AI, Jaganathan K et al. 2019. PubMed ID:30661751). It has been reported with a second DNAI1 pathogenic variant in several individuals with primary ciliary dyskinesia (Blanchon et al. 2020. PubMed ID: 31772028; Cătană et al. 2022.doi: 10.26502/acbr.50170285; Schramm et al. 2023. PubMed ID: 37860582). This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at